1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow SIRT-Y90 with Placebo (IV): new trials by email Literature Review of SIRT-Y90 with Placebo (IV) trials Research Report on SIRT-Y90 with Placebo (IV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo (IV) - Locally Advanced Hepatocellular Carcinoma | Phase 2 | Active not recruiting | National Cancer Centre, Singapore | 119 | 2022-10-26 | 2026-10-20 |
National Cancer Centre, Singapore (1)
China (1) · Singapore (1) · South Korea (1) · Taiwan (1)